(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HEMOCELL

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

HEMOCELL

ST13

US500000086810121

Classe

9, 10

Pedido

86810121

Registro

5514151

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

40

Atualização mais recente

16/03/2025

Tipo de marca

Verbal

Classes Nice

9, 10

Data de depósito

05/11/2015

Data de registro

10/07/2018

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/11/2024

Última transação

16/03/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

20/03/2018

Primeiro uso no comércio

20/03/2018

Código do desenho

4

Tipo de titular

03

Localização do titular

Bedford, MA

Examinador

RIEPEL, CHRISTINA

Localização atual

Historical data usage

Titulares e representantes

Titulares

Instrumentation Laboratory Company

Representantes

Deborah J. Peckham Barclay Damon LLP

Classificação técnica

Classes Nice

Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Hemostasis laboratory automation systemsdata management and laboratory computer hardware; data management and laboratory automation systems comprised of computer hardware and software for use in the fields of hemostasis and medical diagnostics; laboratory equipment for use in the field of clinical research diagnosticsautomation equipment to automate the sorting of laboratory samples and tubesonline sample storagesample transportcentrifugationsample resealing and desealingaliquoting; data management and laboratory computer hardware; data management and laboratory automation systems comprised of computer hardware and software for use in the fields of medical diagnostics and hemostasis

Classe 10

Hemostasis laboratory automation systems and parts thereformedical apparatus for diagnostic testing in the field of hemostasis; laboratory equipment for use in the fields of hemostasis and medical diagnosticsautomation equipment to automate the sorting of laboratory samples and tubes and aliquoting for medical diagnostic use; apparatus and instruments for transferring and sorting blood collecting tubes and sample tubes or containers for samplesall for medical use; medical sample tube sorting apparatus; sample container transfer apparatus for medical purposes; sample rack transfer apparatus for medical purposes; laboratory automation systems for use in the field of hemostasis analysis and medical diagnostics; diagnostic instruments for medical useautomated coagulation analyzers for measuring clotting characteristics and clotting constituents in blood; hemostasis laboratory automation systems comprised of for medical diagnostic instruments for the analysis of body fluids and related data management computer software and hardware sold as a unitstructural parts therefor

Publicações

Histórico de despachos e eventos da marca no USPTO.

40 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/03/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/03/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/03/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/03/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/03/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

21/11/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

21/11/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

21/11/2024

E815

TEAS SECTION 8 & 15 RECEIVED

10/06/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/07/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/07/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/06/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/06/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/06/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/06/2018

IUAF

USE AMENDMENT FILED

11/05/2018

EISU

TEAS STATEMENT OF USE RECEIVED

11/05/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

14/12/2017

EX2G

SOU EXTENSION 2 GRANTED

12/12/2017

EXT2

SOU EXTENSION 2 FILED

12/12/2017

EEXT

SOU TEAS EXTENSION RECEIVED

12/12/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/06/2017

EX1G

SOU EXTENSION 1 GRANTED

06/06/2017

EXT1

SOU EXTENSION 1 FILED

06/06/2017

EEXT

SOU TEAS EXTENSION RECEIVED

06/06/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

13/12/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

18/10/2016

PUBO

PUBLISHED FOR OPPOSITION

18/10/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

28/09/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/09/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/09/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2016

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

09/03/2016

GPRA

PRIORITY ACTION E-MAILED

09/03/2016

CPRA

PRIORITY ACTION WRITTEN

09/03/2016

DOCK

ASSIGNED TO EXAMINER

29/02/2016

MPMK

NOTICE OF PSEUDO MARK E-MAILED

11/11/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/11/2015

NWAP

NEW APPLICATION ENTERED

09/11/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HEMOCELL ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.